Cerebral Cortex,
Journal Year:
2023,
Volume and Issue:
33(22), P. 11025 - 11035
Published: Sept. 23, 2023
This
work
explored
neural
network
changes
in
early
Parkinson's
disease:
Resting-state
functional
magnetic
resonance
imaging
was
used
to
investigate
alterations
different
stages
of
disease
(PD).
Ninety-five
PD
patients
(50
early/mild
and
45
early/moderate)
37
healthy
controls
(HCs)
were
included.
Independent
component
analysis
revealed
significant
differences
intra-network
connectivity,
specifically
the
default
mode
(DMN)
right
frontoparietal
(RFPN),
both
groups
compared
HCs.
Inter-network
connectivity
showed
reduced
between
executive
control
(ECN)
DMN,
as
well
ECN-left
(LFPN),
PD.
Early/moderate
exhibited
decreased
ECN-LFPN,
ECN-RFPN,
ECN-DMN,
DMN-auditory
network,
along
with
increased
LFPN-cerebellar
network.
Correlations
found
ECN-DMN
ECN-LFPN
connections
UPDRS-III
scores
These
findings
suggest
that
progression
involves
dysfunction
multiple
intra-
inter-networks,
particularly
implicating
ECN,
a
wider
range
abnormal
networks
may
mark
disease.
Journal Of Big Data,
Journal Year:
2023,
Volume and Issue:
10(1)
Published: July 10, 2023
Neurological
diseases
are
on
the
rise
worldwide,
leading
to
increased
healthcare
costs
and
diminished
quality
of
life
in
patients.
In
recent
years,
Big
Data
has
started
transform
fields
Neuroscience
Neurology.
Scientists
clinicians
collaborating
global
alliances,
combining
diverse
datasets
a
massive
scale,
solving
complex
computational
problems
that
demand
utilization
increasingly
powerful
resources.
This
revolution
is
opening
new
avenues
for
developing
innovative
treatments
neurological
diseases.
Our
paper
surveys
Data's
impact
patient
care,
as
exemplified
through
work
done
comprehensive
selection
areas,
including
Connectomics,
Alzheimer's
Disease,
Stroke,
Depression,
Parkinson's
Pain,
Addiction
(e.g.,
Opioid
Use
Disorder).
We
present
an
overview
research
methodologies
utilizing
each
area,
well
their
current
limitations
technical
challenges.
Despite
potential
benefits,
full
these
currently
remains
unrealized.
close
with
recommendations
future
aimed
at
optimizing
use
Neurology
improved
outcomes.The
online
version
contains
supplementary
material
available
10.1186/s40537-023-00751-2.
Frontiers in Aging Neuroscience,
Journal Year:
2022,
Volume and Issue:
14
Published: March 3, 2022
Parkinson's
disease
(PD)
is
one
of
the
most
common
progressive
degenerative
diseases,
and
its
diagnosis
challenging
on
clinical
grounds.
Clinically,
effective
quantifiable
biomarkers
to
detect
PD
are
urgently
needed.
In
our
study,
we
analyzed
data
from
two
centers,
primary
set
was
used
train
model,
independent
external
validation
validate
model.
We
applied
amplitude
low-frequency
fluctuation
(ALFF)-based
radiomics
method
extract
features
(including
first-
high-order
features).
Subsequently,
Journal of Parkinson s Disease,
Journal Year:
2024,
Volume and Issue:
14(s2), P. S353 - S365
Published: Feb. 6, 2024
Assessing
imaging
biomarker
in
the
prodromal
and
early
phases
of
Parkinson’s
disease
(PD)
is
great
importance
to
ensure
an
safe
diagnosis.
In
last
decades,
modalities
advanced
are
now
able
assess
many
different
aspects
neurodegeneration
PD.
MRI
sequences
can
measure
iron
content
or
neuromelanin.
Apart
from
SPECT
with
Ioflupane,
more
specific
PET
tracers
degeneration
dopaminergic
system
available.
Furthermore,
metabolic
patterns
be
used
anticipate
a
phenoconversion
PD
manifest
this
regard,
it
worth
mentioning
that
inflammation
will
gain
significance.
Molecular
neurotransmitters
like
serotonin,
noradrenaline
acetylcholine
shed
light
on
non-motor
symptoms.
Outside
brain,
molecular
heart
gut
PD-related
autonomous
nervous
system.
Moreover,
optical
coherence
tomography
noninvasively
detect
retinal
fibers
as
potential
review,
we
describe
these
state-of-the-art
point
out
how
far
techniques
future
pave
way
towards
biomarker-based
staging
Human Brain Mapping,
Journal Year:
2023,
Volume and Issue:
44(6), P. 2176 - 2190
Published: Jan. 20, 2023
Abstract
Differentiating
the
parkinsonian
variant
of
multiple
system
atrophy
(MSA‐P)
from
idiopathic
Parkinson's
disease
(IPD)
is
challenging,
especially
in
early
stages.
This
study
aimed
to
investigate
differences
and
similarities
brain
functional
connectomes
IPD
MSA‐P
patients
use
machine
learning
methods
explore
diagnostic
utility
these
features.
Resting‐state
fMRI
data
were
acquired
88
healthy
controls,
76
patients,
53
using
a
3.0
T
scanner.
The
whole‐brain
connectome
was
constructed
by
thresholding
Pearson
correlation
matrices
116
regions,
topological
properties
evaluated
through
graph
theory
approaches.
Connectome
measurements
used
as
features
models
(random
forest
[RF]/logistic
regression
[LR]/support
vector
machine)
distinguish
patients.
Regarding
metrics,
shared
network
properties.
Both
patient
groups
showed
connectivity
disruptions
within
cerebellum‐basal
ganglia‐cortical
network,
but
disconnections
mainly
cortico‐thalamo‐cerebellar
circuits
basal
ganglia‐thalamo‐cortical
Among
parameters,
t
tests
combined
with
RF
method
identified
15
features,
which
LR
classifier
achieved
best
performance
on
validation
set
(accuracy
=
92.31%,
sensitivity
90.91%,
specificity
93.33%,
area
under
receiver
operating
characteristic
curve
0.89).
show
similar
alterations.
primarily
affects
cerebellar
nodes,
ganglia
nodes;
both
conditions
disrupt
network.
Moreover,
parameters
outstanding
value
differential
diagnosis
IPD.
Headache The Journal of Head and Face Pain,
Journal Year:
2024,
Volume and Issue:
64(7), P. 825 - 837
Published: June 4, 2024
Abstract
Objective
In
this
pilot
prospective
cohort
study,
we
aimed
to
evaluate,
using
high‐density
electroencephalography
(HD‐EEG),
the
longitudinal
changes
in
functional
connectivity
(FC)
patients
with
chronic
migraine
(CM)
treated
onabotulinumtoxinA
(OBTA).
Background
OBTA
is
a
treatment
for
CM.
Several
studies
have
shown
modulatory
action
of
on
central
nervous
system;
however,
research
limited.
Methods
This
study
was
conducted
at
Neurology
Unit
“Policlinico
Tor
Vergata,”
Rome,
Italy,
and
included
12
adult
CM
15
healthy
controls
(HC).
Patients
underwent
clinical
scales
enrollment
(T0)
3
months
(T1)
from
start
treatment.
HD‐EEG
recorded
64‐channel
system
T0
T1.
A
source
reconstruction
method
used
identify
brain
activity.
FC
δ‐θ‐α‐β‐low‐γ
bands
analyzed
weighted
phase‐lag
index.
between
HCs
T1
were
assessed
cross‐validation
methods
estimate
results’
reliability.
Results
Compared
T0,
showed
hyperconnected
networks
δ
(
p
=
0.046,
area
under
receiver
operating
characteristic
curve
[AUC:
0.76‐0.98],
Cohen's
κ
[0.65‐0.93])
β
0.031,
AUC
[0.68‐0.95],
[0.51‐0.84]),
mainly
involving
orbitofrontal,
occipital,
temporal
pole
superior
temporal,
cingulate
areas,
hypoconnected
α
band
0.029,
[0.80‐0.99],
[0.42‐0.77]),
predominantly
cingulate,
pole,
precuneus.
T1,
compared
0.032,
[0.73‐0.99],
[0.53‐0.90])
0.048,
[0.58‐0.93],
[0.37‐0.78]),
sensorimotor,
cortex.
Conclusion
These
preliminary
results
that
presented
disrupted
EEG‐FC
restored
by
single
session
treatment,
suggesting
primary
OBTA.
Cerebral Cortex,
Journal Year:
2024,
Volume and Issue:
34(7)
Published: July 1, 2024
Abstract
Autonomic
symptoms
in
Parkinson’s
disease
result
from
variable
involvement
of
the
central
and
peripheral
systems,
but
many
aspects
remain
unclear.
The
analysis
functional
connectivity
has
shown
promising
results
assessing
pathophysiology
disease.
This
study
aims
to
investigate
association
between
autonomic
cortical
early
patients
using
high-density
EEG.
53
(F/M
18/35)
49
controls
20/29)
were
included.
evaluated
Scales
for
Outcomes
disease–Autonomic
Dysfunction
score.
Data
recorded
with
a
64-channel
EEG
system.
We
analyzed
connectivity,
based
on
weighted
phase-lag
index,
θ-α-β-low-γ
bands.
A
network-based
statistic
was
used
perform
linear
regression
score
patients.
observed
positive
relation
α-functional
(network
τ
=
2.8,
P
0.038).
Regions
higher
degrees
insula
limbic
lobe.
Moreover,
we
found
correlations
mean
this
network
gastrointestinal,
cardiovascular,
thermoregulatory
domains
Dysfunction.
Our
revealed
abnormal
specific
areas
greater
symptoms.
Insula
play
significant
role
regulation
Increased
these
regions
might
represent
compensatory
mechanism
dysfunction
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 19, 2025
Cognitive
decline
is
common
in
Parkinson's
disease
(PD).
Reliance
on
neuropsychological
testing
alone
can
lead
to
delayed
identification,
and
an
objective
comprehensive
approach
needed
clinical
practice.
We
assessed
brain
functional
connectivity
during
PD-MCI
(mild
cognitive
impairment)
PD-NC
(normal
cognition)
patients,
healthy
controls
(HC)
completing
the
Stroop
color-word
test
(SCWT)
using
near-infrared
spectroscopy
(fNIRS),
explored
predictive
value
of
combining
relevant
function
behavioral
information
for
general
PD.
Nineteen
patients
with
PD-MCI,
21
33
age-matched
HC
were
recruited.
Group
differences
executive
performance
prefrontal
analyzed.
Receiver
operating
characteristic
analysis
was
used
measure
motor
predicting
PD-MCI.
During
incongruent
test,
had
significantly
lower
correct
rate
than
patients.
Meanwhile,
exhibited
increased
regional
strength
left
right
cortex
(RSl,
RSr),
global
efficiency
HC,
compared
PD-NC,
showed
higher
RSr.
For
PD
MMSE
score
negatively
associated
RSr
after
adjusting
education
level
age.
After
combined
RSr,
MDS-UPDRS
III
score,
diagnostic
sensitivity
specificity
reached
0.737
0.810,
respectively,
area
under
curve
0.830.
proposed
a
signature
PD,
which
could
provide
new
insights
into
early
detection
intervention
this
problem.